Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07634835 · ClinicalTrials.gov registry record · NA

Transcranial Magnetic Stimulation for Adolescents and Young Adults With Cannabis Use Disorder

A NA study, sponsored by University of Minnesota.

Not yet
Registry status
NA
Development phase
50
Enrollment target

NCT07634835: Clinical Trial NA study, sponsored by University of Minnesota.

NCT07634835 is a NA study that has not yet begun recruiting, run by University of Minnesota. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07634835, a NA study, has not yet begun recruiting, sponsored by University of Minnesota.

NOT YET RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target

Study Summary

This pilot study will investigate the potential of repetitive transcranial magnetic stimulation (rTMS) to strengthen a neural circuit critical for maintaining abstinence in adolescents and youth with cannabis use disorder (CUD).

Primary Outcome

Daily side-effects reports on each intervention day and an exit interview will be collected.

Interventions

  • DEVICE Sham rTMS
  • DEVICE Magstim SuperRapid2

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2027-03-01
Est. Completion 2029-03-31
Phase NA
University of Minnesota

966 total trials

What is known before NCT07634835 opens enrollment

NCT07634835 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 2 interventions - of which Sham rTMS is the first listed.

NCT07634835 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07634835 about?

NCT07634835 is a clinical study titled "Transcranial Magnetic Stimulation for Adolescents and Young Adults With Cannabis Use Disorder". This pilot study will investigate the potential of repetitive transcranial magnetic stimulation (rTMS) to strengthen a neural circuit critical for maintaining abstinence in adolescents and youth with cannabis use disorder (CUD).

What is the current status of trial NCT07634835?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2027-03-01. Estimated completion is 2029-03-31.

What interventions are being tested in trial NCT07634835?

The interventions under investigation include: Sham rTMS (DEVICE), Magstim SuperRapid2 (DEVICE).

Who is sponsoring clinical trial NCT07634835?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07634835's enrollment target sits among peer trials

50 1279th of 2000 higher than 622 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07634835, the US trial registry maintained by the National Library of Medicine. NCT07634835 (small enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.